Investigation of inhibition of human glucose 6-phosphate dehydrogenase by some 99mTc chelators by in silico and in vitro methods

References

• Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008;371:64–74
   PubMed Web of Science ®Google Scholar
• Sahin A, Senturk M, Ciftci M, et al. Effects of thallium-201 and radioactivity on human erythrocyte glucose 6-phosphate dehydrogenase activity. Nucl Med Biol 2010;37:389–94
   PubMed Web of Science ®Google Scholar
• Kuo W, Lin J, Tang TK. Human glucose-6-phosphate dehydrogenase (G6PD) gene transforms nih 3t3 cells and induces tumors in nude mice. Int J Cancer 2000;85:857–64
   PubMed Web of Science ®Google Scholar
• Beutler E. G6PD deficiency. Blood 1994;84:3613–36
   PubMed Web of Science ®Google Scholar
• Bergmeyer HU, Grassl M, Walter HE. In: Bergmeyer HU, ed. Methods of enzymatic analysis. 3rd ed. Vol. II. Deerfield Beach, FL: Verlag Chemie; 1983: pp. 222–3
   Google Scholar
• Senturk M, Kufrevioglu OI, Ciftci M. Effects of some antibiotics on human erythrocyte glutathione reductase: an in vitro study. J Enzyme Inhib Med Chem 2008;23:144–8
   PubMed Web of Science ®Google Scholar
• Kanji MI, Toews ML, Carpar WR. A kinetic study of glucose 6-phosphate dehydrogenase. J Biol Chem 1976;25:2258–62
   Google Scholar
• Jacquin C, Nasica X, Guillard D, et al. Intravitreal treatment of endophthalmitis. Méd Maladies Infect 2001;3:1493–7
   Google Scholar
• Senturk M, Ceyhun SB, Erdogan O, Kufrevioglu OI. In vitro and in vivo effects of some pesticides on glucose-6-phosphate dehydrogenase enzyme activity from rainbow trout (Oncorhynchus mykiss) erythrocytes. Pestic Biochem Phys 2009;95:95–9
   Web of Science ®Google Scholar
• Mousa SA, Williams SJ, Sands H. Characterization of in vivo chemistry of cations in the heart. J Nucl Med 1987;28:1351–7
   PubMed Web of Science ®Google Scholar
• Hjelstuen OK. Technetium-99m chelators in nuclear medicine. A review Analyst 1995;120:863–6
   PubMed Web of Science ®Google Scholar
• Lever SZ, Wagner Jr HN. Technetium and rhenium in chemistry and nuclear medicine 3, Cortina International, Verona; 1990, pp. 649–59
   Google Scholar
• Meerdink DJ, Leppo JA. Experimental studies of the physiologic properties of technetium-99m agents: myocardial transport of perfusion imaging agents. Am J Cardiol 1990;66:9–15
   Web of Science ®Google Scholar
• Hanson RN. Radiopharmaceuticals structure-activity relationships. New York: Grune and Stratton; 1981:314–16
   Google Scholar
• Ciftci M, Kufrevioglu OI, Gundogdu M, Ozmen I. Effects of some antibiotics on enzyme activity of glucose-6-phosphate dehydrogenase from human erythrocytes. Pharmacol Res 2000;41:109–13
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–51
   PubMed Web of Science ®Google Scholar
• Laemmli DK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–3
   PubMed Web of Science ®Google Scholar
• Beutler E. Red cell metabolism manual of biochemical methods. London: Academic Press; 1971
   Google Scholar
• Coban TA, Senturk M, Ciftci M, Kufrevioglu OI. Effects of some metal ions on human erythrocyte glutathione reductase: an in vitro study. Protein Pept Lett 2007;14:1027–30
   PubMed Web of Science ®Google Scholar
• Kotaka M, Gover S, Vandeputte-Rutten L, et al. Structural studies of glucose-6-phosphate and NADP+ binding to human glucose-6-phosphate dehydrogenase. Acta Crystallogr Sect D: Biol Crystallogr 2005;495–504
   PubMedGoogle Scholar
• Siu SWI, Pluhackova K, Böckmann RA. Optimization of the OPLS-AA force field for long hydrocarbons. J Chem Theory Comput 2012;8:1459–70
   PubMed Web of Science ®Google Scholar
• Schrödinger Release 2015-3: Maestro, version 10.3, Schrödinger, LLC, New York, NY; 2015
   Google Scholar
• Schrödinger Release 2014-4: LigPrep, version 3.2, Schrödinger, LLC, New York, NY; 2014
   Google Scholar
• Friesner R. a, Banks JL, Murphy RB, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy. J Med Chem 2004;47:1739–49
   PubMed Web of Science ®Google Scholar
• Jacobson MP, Pincus DL, Rapp CS, et al. A hierarchical approach to all-atom protein loop prediction. Proteins Struct Funct Genet 2004;55:351–67
   PubMed Web of Science ®Google Scholar
• Sherman W, Day T, Jacobson MP, et al. Novel procedure for modeling ligand/receptor induced fit effects. J Med Chem 2006;49:534–53
   PubMed Web of Science ®Google Scholar
• D. E. Shaw Research. Desmond Molecular Dynamics System, version 2.2, Maestro-Desmond Interoperability Tools, version 2.2, Schrödinger. New York, NY, USA; 2009.
   Google Scholar
• Laurence DR, Bennett PN, Brown MJ. Clinical Pharmacology. 8th ed. Singapore: Churchill Livingstone; 1997
   Google Scholar
• Morelli A, Benatti U, Gaetani GF, De Flora A. Biochemical mechanisms of glucose-6-phosphate dehydrogenase deficiency. Proc Natl Acad Sci USA 1978;75:1979–83
   PubMed Web of Science ®Google Scholar
• Altikat S, Ciftci M, Büyükokuroglu ME. In vitro effects of some anesthetic drugs on enzymatic activity of human red blood cell glucose 6-phosphate dehydrogenase. Pol J Pharmacol 2002;54:67–71
   PubMedGoogle Scholar
• Senturk M, Kufrevioglu OI, Ciftci M. Effects of some analgesic anaesthetic drugs on human erythrocyte glutathione reductase: an in vitro study. J Enzyme Inhib Med Chem 2009;24:420–4
   PubMed Web of Science ®Google Scholar
• Akkemik E, Senturk M, Ozgeris FB, et al. In vitro effects of some drugs on human erythrocyte glutathione reductase. Turk J Med Sci 2011;41:235–41
   Web of Science ®Google Scholar
• Sahin A, Senturk M, Akkemik E, Ciftci M. The effects of chemical and radioactive properties of Tl-201 on human erythrocyte glutathione reductase activity. Nucl Med Biol 2012;39:161–5
   PubMed Web of Science ®Google Scholar
• Senturk M, Alici HA, Beydemir S, Kufrevioglu OI. In vitro and in vivo effects of some benzodiazepine drugs on human and rabbit erythrocyte carbonic anhydrase enzymes. J Enzyme Inhib Med Chem 2012;27:680–4
   PubMed Web of Science ®Google Scholar
• Fidan I, Salmas RE, Arslan M, et al. Carbonic anhydrase inhibitors: design, synthesis, kinetic, docking and molecular dynamics analysis of novel glycine and phenylalanine sulphonamide derivatives. Bioorg Med Chem 2015;23:7353–8
   PubMed Web of Science ®Google Scholar
• Cakmak R, Durdagi S, Ekinci D, et al. Design, synthesis and biological evaluation of novel nitroaromatic compounds as potent glutathione reductase inhibitors. Bioorg Med Chem Lett 2011;21:5398–402
   PubMed Web of Science ®Google Scholar
• Durdagi S, Papadopoulos MG, Papahatjis DP, Mavromoustakos T. Combined 3D QSAR and molecular docking studies to reveal novel cannabinoid ligands with optimum binding activity. Bioorg Med Chem Lett 2007;17:6754–63
   PubMed Web of Science ®Google Scholar
• Fotakis C, Gega S, Siapi E, et al. Interactions at the bilayer interface and receptor site induced by the novel synthetic pyrrolidinone analog MMK3. Biochim Biophys Acta 2010;1798:422–32
   PubMed Web of Science ®Google Scholar
• Durdagi S, Senturk M, Ekinci D, et al. Kinetic and docking study of phenol-based inhibitors of carbonic anhydrase isoform I, II, IX and XII evidence a new binding mode within the enzyme active site. Bioorg Med Chem 2011;19:1381–9
   PubMed Web of Science ®Google Scholar
• Isık S, Vullo D, Durdagi S, et al. Interaction of carbonic anhydrase isozymes I, II, and IX with some pyridine and phenol hydrazinecarbothioamide derivatives. Bioorg Med Chem Lett 2015;25:5636–41
   PubMed Web of Science ®Google Scholar
• Balaydin HT, Durdagi S, Ekinci D, et al. Inhibition of human carbonic anhydrase isozymes I, II and VI with A series of bisphenol, methoxy and bromophenol compounds. J Enzyme Inhib Med Chem 2012;27:467–75
   PubMed Web of Science ®Google Scholar
• Durdagi S, Guo J, Lees-Miller J, et al. Structure-guided topographic mapping and mutagenesis to elucidate binding sites for the Herg1 potassium channel (KCNH2) activator-NS1643. J Pharmacol Exp Ther 2012;342:441–52
   PubMed Web of Science ®Google Scholar
• Ekinci D, Cavdar H, Durdagi S, et al. Structure-activity relationships for the interaction of 5,10-dihydroindeno[1,2-b]indole derivatives with human and bovine carbonic anhydrase isoforms I, II, III, IV, and VI. Eur J Med Chem 2012;49:68–73
   PubMed Web of Science ®Google Scholar
• Balaydin HT, Senturk M, Goksu S, Menzek A. Synthesis and carbonic anhydrase inhibitory properties of novel bromophenols and their derivatives including natural products: vidalol B. Eur J Med Chem 2012;54:423–8
   PubMed Web of Science ®Google Scholar
• Ekinci D, Şentürk M, Şentürk E. Purification and characterization of carbonic anhydrase enzyme from bovine heart tissue and investigation of inhibition effects of some sulphonamide derivative drugs. Acta Physiologica 2015;215:99
   Google Scholar